Imakethe yamasheya, ukuhwebelana kwamasheya namuhla
Ukucaphuna kwamasheya ezinkampanini ezingu-71229 ngesikhathi sangempela.
Imakethe yamasheya, ukuhwebelana kwamasheya namuhla

Izingcaphuno ze-Stock

Ukucaphuna kwamasheya ku-inthanethi

Umlando ucaphuna umlando

I-capital market capital

Izigaba ze-Stock

Inzuzo evela kumasheya enkampani

Imibiko yezezimali

Amanani wokulinganisa wezinkampani. Kukuphi ukutshalwa imali?

Izimali Magenta Therapeutics, Inc.

Bika imiphumela yemali yenkampani Magenta Therapeutics, Inc., Magenta Therapeutics, Inc. engenayo yonyaka ngonyaka ka-2024. Magenta Therapeutics, Inc. ishicilela nini imibiko yezezimali?
Engeza kumawijethi
Ingeziwe kumawijethi

Magenta Therapeutics, Inc. isamba semali engenayo, imali engenayo yonke kanye nezinguquko zezinguquko eziguqwini US dollar namuhla

Magenta Therapeutics, Inc. ngezikhathi zokubika ezimbalwa ezedlule. Imali engenayo ye-Magenta Therapeutics, Inc. ku- 31/03/2021 ifinyelela ku- 0 $. Amandla we- Magenta Therapeutics, Inc. imali engenayo iyonke inyuke ngo-0 $ kusukela ngesikhathi sokubika sokugcina. Ishadi lombiko wezezimali libonisa amanani asuka ku- 30/06/2018 kuya ku- 31/03/2021. Imininingwane esezingeni le- Magenta Therapeutics, Inc. imali engenayo yonke eshadini elikuleli khasi idwetshwa ngemigoqo eluhlaza okwesibhakabhaka. Inani lawo wonke amafa we- Magenta Therapeutics, Inc. igrafu ikhonjiswe luhlaza.

Usuku lokubika Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
futhi Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
futhi Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
31/03/2021 0 $ - -17 489 000 $ -
31/12/2020 0 $ - -18 168 000 $ -
30/09/2020 0 $ - -17 678 000 $ -
30/06/2020 0 $ - -19 079 000 $ -
31/03/2019 0 $ - -14 834 000 $ -
31/12/2018 0 $ - -16 679 000 $ -
30/09/2018 0 $ - -16 015 000 $ -
30/06/2018 0 $ - -13 660 000 $ -
Bonisa:
Ukuze

Umbiko wezezimali Magenta Therapeutics, Inc., isimiso

Izinsuku ze- Magenta Therapeutics, Inc.: 30/06/2018, 31/12/2020, 31/03/2021. Izinsuku nezinsuku zezitatimende zezezimali kusungulwa yimithetho yezwe lapho inkampani isebenza khona. Usuku lwakamuva lombiko wezezimali we Magenta Therapeutics, Inc. yi 31/03/2021. Imali engenayo yokusebenza Magenta Therapeutics, Inc. iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo. Imali engenayo yokusebenza Magenta Therapeutics, Inc. kuyinto -18 697 000 $

Izinsuku zembiko yezimali Magenta Therapeutics, Inc.

Imali engenayo Magenta Therapeutics, Inc. iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika. Imali engenayo Magenta Therapeutics, Inc. kuyinto -17 489 000 $ Izindleko zokusebenza Magenta Therapeutics, Inc. yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi. Izindleko zokusebenza Magenta Therapeutics, Inc. kuyinto 18 697 000 $ Imali yamanje Magenta Therapeutics, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali yamanje Magenta Therapeutics, Inc. kuyinto 49 289 000 $

Ukulingana Magenta Therapeutics, Inc. yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele. Ukulingana Magenta Therapeutics, Inc. kuyinto 129 059 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Inzuzo enkulu
Inzuzo eyinzuzo yinzuzo eyenziwa yinkampani ngemuva kokunciphisa izindleko zokukhiqiza nokuthengisa imikhiqizo yayo kanye / noma izindleko zokuhlinzeka ngezinsizakalo zayo.
- - - - - - - -
Inani lentengo
Izindleko yizindleko eziphelele zokukhiqizwa nokusatshalaliswa kwemikhiqizo namasevisi yenkampani.
- - - - - - - -
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
- - - - - - - -
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyinzuzo evela ebhizinisini lenhloko yenkampani. Isibonelo, umthengisi udala imali engenayo ngokusebenzisa ukudayiswa kwezimpahla, kanti udokotela uthola inzuzo emisebenzini yezokwelapha ayinikezayo.
- - - - - - - -
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo.
-18 697 000 $ -19 065 000 $ -18 381 000 $ -20 012 000 $ -16 350 000 $ -17 930 000 $ -16 702 000 $ -14 025 000 $
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
-17 489 000 $ -18 168 000 $ -17 678 000 $ -19 079 000 $ -14 834 000 $ -16 679 000 $ -16 015 000 $ -13 660 000 $
Izindleko ze-R & D
Izindleko zokucwaninga nezentuthuko - izindleko zocwaningo zokuthuthukisa imikhiqizo nezinqubo ezikhona noma ukuthuthukisa imikhiqizo nezinqubo ezintsha.
11 728 000 $ 12 256 000 $ 11 786 000 $ 12 610 000 $ 10 537 000 $ 12 390 000 $ 11 418 000 $ 9 683 000 $
Izindleko zokusebenza
Izindleko zokusebenza yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi.
18 697 000 $ 19 065 000 $ 18 381 000 $ 20 012 000 $ 16 350 000 $ 17 930 000 $ 16 702 000 $ 14 025 000 $
Amafa wamanje
Izimpahla zamanje ziyingxenye yebhalansi emela ukubaluleka kwazo zonke izimpahla ezingashintshwa zibe yikheshi phakathi nonyaka owodwa.
135 096 000 $ 151 527 000 $ 164 267 000 $ 179 877 000 $ 135 077 000 $ 145 321 000 $ 162 864 000 $ 175 926 000 $
Inani lempahla
Ingqikithi yempahla iyinani elilingana nengqikithi yenani eliphelele lenhlangano, amanothi esikweletu, nempahla ebonakalayo.
144 620 000 $ 161 619 000 $ 174 641 000 $ 190 727 000 $ 147 692 000 $ 157 313 000 $ 172 793 000 $ 180 618 000 $
Imali yamanje
Imali yamanje yimali yonke imali egcinwe yinkampani ngosuku lombiko.
49 289 000 $ 58 152 000 $ 141 680 000 $ 136 287 000 $ 31 241 000 $ 58 345 000 $ 159 674 000 $ 173 429 000 $
Isikweletu samanje
Isikweletu samanje siyingxenye yesikweletu esikhokhwa phakathi nonyaka (izinyanga ezingu-12) futhi siboniswa njengesibophezelo samanje kanye nengxenye yenani elisebenzayo.
- - - - 7 920 000 $ 10 419 000 $ 11 929 000 $ 7 605 000 $
Inani lemali
Ingqikithi yenkokhelo yinani lazo zonke imali enkampani enayo kuma-akhawunti ayo, kufaka phakathi imali encane nemali ebanjwe ebhange.
- - - - - - - -
Isikweletu sonke
Ingqikithi yesikweletu iyinhlanganisela yesikweletu sesikhashana nesikhathi eside. Izikweleti zesikhashana esifushane yizo okufanele zibuyiselwe phakathi nonyaka. Isikweletu sesikhathi eside sihlanganisa zonke izikweletu okufanele zibuyiselwe ngemuva konyaka owodwa.
- - - - 13 689 000 $ 11 665 000 $ 13 009 000 $ 8 401 000 $
Isikweletu sesilinganiso
Ingqikithi yesamba semali ephelele yezimpahla yi-ratio yezezimali ekhombisa iphesenti yezimpahla zenkampani ezimele njengesikweletu.
- - - - 9.27 % 7.42 % 7.53 % 4.65 %
Ukulingana
Ukulingana yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele.
129 059 000 $ 143 906 000 $ 158 566 000 $ 173 914 000 $ 134 003 000 $ 145 648 000 $ 159 784 000 $ 172 217 000 $
Ukugeleza kwemali
Ukugeleza kwezimali kuyinani eliphelele lemali kanye nezilinganiso zemali ezihamba enhlanganweni.
- - - - -14 936 000 $ -12 624 000 $ -10 549 000 $ -9 109 000 $

Umbiko wamuva wezezimali ngemali engenayo Magenta Therapeutics, Inc. kwakungu-31/03/2021. Ngokombiko wamuva ngemiphumela yezezimali ye-Magenta Therapeutics, Inc., imali engenayo ye-Magenta Therapeutics, Inc. yayingu-0 US dollar futhi ishintshwe yaba ngu-0% uma kuqhathaniswa nonyaka odlule. Inzuzo enenetha ye Magenta Therapeutics, Inc. engxenyeni yokugcina yayingu--17 489 000 $, inzuzo enenzuzo ishintshwe ngu-0% uma kuqhathaniswa nonyaka odlule.

Izindleko zamasheya Magenta Therapeutics, Inc.

Izezimali Magenta Therapeutics, Inc.